Samsung Biologics Dividend yield

Samsung Biologics is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Samsung Biologics is a company from Korea, and his stocks are publicly traded.

Samsung Biologics stock dividend

Samsung Biologics paid a total dividend of 0 million KRW last year, for a market value of 52,327,000 millions (Market Cap 12,988,965 millions). Samsung Biologics dividend per share is 0.00 KRW, and his stock market price 737,000.00 KRW.

According to the chart below where dividend yield is displayed, Samsung Biologics, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Korea, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Samsung Biologics might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Samsung Biologics stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high Korea dividend stocks list.

Samsung Biologics Dividend Payout

About the ability of Samsung Biologics to maintain his current dividend of KRW 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Samsung Biologics payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Samsung Biologics, compared againt world market average, Korea companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Samsung Biologics Dividend History

Below you will find a table with the historical evolution of Samsung Biologics's dividend stock, both in percentage and in KRW, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	KRW	Paypout	Shares*
Present	0.00%	0.00	0.00%	71
2022	0.00%	0.00	0.00%	71
2021	0.00%	0.00	0.00%	66
2020	0.00%	0.00	0.00%	66
2019	0.00%	0.00	0.00%	66
2018	0.00%	0.00	0.00%	66
2017	0.00%	0.00	0.00%	66
2016	0.00%	0.00	0.00%	66

*In millions

Samsung Biologics Stock performance

Finally, last moth Samsung Biologics showed a return of -3.80% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -11.70% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Korea and Pharmaceuticals and Biotechnology firms.